• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BRANCHBURG STRATTICE PERFORATED 16 X 20; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BRANCHBURG STRATTICE PERFORATED 16 X 20; MESH, SURGICAL Back to Search Results
Catalog Number 1620002P
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Abscess (1690); Adhesion(s) (1695); Cellulitis (1768); Seroma (2069); Hernia (2240); Obstruction/Occlusion (2422); Post Operative Wound Infection (2446)
Date of Event 09/19/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The lot associated with this event was not reported and remains unknown; therefore a review into the device history records could not be performed.No strattice devices were returned for evaluation.Based on the limited information, and without relevant patient factors, a relationship between the event and the strattice could not be determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
 
Event or Problem Description
Limited information was reported through a legal event that a patient was implanted with strattice on (b)(6) 2019.The form also indicates that on an unspecified date, the strattice implant had been ¿removed or revised¿.No information was provided on the indication for the initial surgery or the reason for the removal or revision.
 
Additional Manufacturer Narrative
This is a known potential adverse event addressed in the product labeling.Without relevant patient factors, a relationship between the strattice and this event could not be determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.Additional and/or corrected data: a2, b3, b5, b6, b7, d4, d6b, h6.
 
Event or Problem Description
This is follow up#1 to report on 27/aug/2025, pmqa received notification from legal that the plaintiff profile form was received associated with this event.As per the ppf form, the patient underwent a incisional hernia surgery and was implanted with a strattice device lot #sp200007, ref.# (b)(4) on (b)(6) 2019.Capturing catalog number as 1620002p.On (b)(6) 2020, patient underwent primary repair of small incisional hernia.On (b)(6) 2022, exploratory laparotomy with lysis of adhesions and removal of foreign body performed.Patient also underwent evacuation of abdominal wall seroma and repair of ventral hernia.On (b)(6) 2023, another exploratory laparotomy, lysis of adhesions, with a removal of infected mesh, reduction and repair of recurrent ventral hernia.Wound vac placement into abdominal wall tap block.On (b)(6) 2023, patient underwent open complex abdominal wall reconstruction with myofascial release of the rectus sheath x2, resection of redundant skin and subcutaneous tissue.Patient was implanted with a non-abbvie device, bard mesh soft, lot #huhs0593.The form lists the condition that was treated: (b)(6) 2019 - explantation of hernia mesh, debridement and drainage of intra-abdominal abscess, partial small bowel resection with anastomosis, placement of retro rectus biologic mesh for hernia repair (stratus); wound vac.(b)(6) 2019 - post-op abdominal wall seroma; placement of pigtail catheter, seroma fluid drained (in-office procedure).(b)(6) 2019 - abdominal pain and swelling; placement of percutaneous drain and seroma/abscess fluid drained (bedside procedure).(b)(6) 2020 - primary repair of small incisional hernia.(b)(6) 2022 - worsening abdominal pain, n/v, small bowel obstruction, abdominal wall hernia, chronic seroma.(b)(6) 2022 - exploratory laparotomy, lysis of adhesions, removal of foreign body, evacuation of abdominal wall seroma, repair of ventral hernia.2023 - recurrent midline abdominal seroma: pigtail catheter placements, multiple aspirations of seroma.(b)(6) 2023 - abdominal wall cellulitis, seroma, infection, and abscess; exploratory laparotomy, lysis of adhesions, removal of infected mesh.2023-2024 - home healthcare; wound management; wound vac management mesh, reduction and repair of recurrent ventral hernia, wound vac placement, abdominal wall tap block.(b)(6) 2023 - abdominal pain, n/v; small bowel obstruction, incarcerated hernia (conservative treatment).(b)(6) 2023 - abdominal pain, n/v; small bowel obstruction; ventral hernia with obstruction.(b)(6) 2023 - recurrent small bowel obstruction (conservative treatment).(b)(6) 2023 - abdominal pain, n/v; open complex abdominal wall reconstruction with myofascial release of the rectus sheath x2, resection of redundant skin and subcutaneous tissue (bard mesh implanted); debridement ct abdomen/pelvis: moderate to high-grade small bowel obstruction.(b)(6) 2023 - partial dehiscence of incision site.Nov (b)(6) 2024 - home healthcare; wound management.(b)(6) 2023 - skin red and indurated in lower midline abdominal wound, abdominal wall cellulitis.(b)(6) 2023 - wound infection, subcutaneous wound seroma, superficial wound dehiscence, placement of percutaneous pigtail catheter (aspiration/drainage) (local used).2023, 2024 - wound management.From 2019 to present - hernia symptoms, hernia surgeries and repair, bowel obstructions, abdominal wall reconstruction, follow-ups, wound management.Various dates 2023-2024 - fluoroscopic drain injections with sclerotherapy, removal of drainage catheters, percutaneous catheter placements (for abdominal abscesses/seroma drainages/aspirations).2019-2023 - abdominal wall seroma/abscess; ct and us scans, seroma/abscess drainages.2018-present - hernia symptoms, follow-ups, wound management, primary care, anxiety, depression.As reported in the initial: limited information was reported through a legal event that a patient was implanted with strattice on (b)(6) 2019.The form also indicates that on an unspecified date, the strattice implant had been ¿removed or revised¿.No information was provided on the indication for the initial surgery or the reason for the removal or revision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATTICE PERFORATED 16 X 20
Common Device Name
MESH, SURGICAL
Manufacturer (Section D)
BRANCHBURG
one millennium way
branchburg NJ 08876
Manufacturer (Section G)
LIFECELL
one millennium way
branchburg NJ 08876
Manufacturer Contact
christopher belle
1 millennium way
branchburg, NJ 08876
8479366324
MDR Report Key20152867
Report Number1000306051-2024-00237
Device Sequence Number4235730
Product Code FTM
UDI-Device Identifier00818410012298
UDI-Public(01)00818410012298
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
K150712
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 09/02/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number1620002P
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/27/2024
Supplement Date Received by Manufacturer08/27/2025
Initial Report FDA Received Date09/05/2024
Supplement Report FDA Received Date09/02/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age64 YR
Patient SexFemale
-
-